In addition, TRPV2 is expressed in human multiple myeloma cells and promotes osteoclastogenesis by enhancing the expression of receptor activator of nuclear factor-kappa B ligand (RANKL), which is essential for osteoclast differentiation30. This evidence concerns the gene TNFSF11 and plasma cell myeloma.